Yun LONG

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Substituted quinazolines as inhibitors of KRAS G12C
- Patent number 11,878,985
- Issue date Jan 23, 2024
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazole derivatives, and pharmaceutical compositions and meth...
- Patent number 11,787,788
- Issue date Oct 17, 2023
- Capella Therapeutics, Inc.
- Yun Long
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...
- Patent number 11,713,322
- Issue date Aug 1, 2023
- Capella Therapeutics, Inc.
- Yun Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzimidazoles for use in the treatment of cancer and inflammatory...
- Patent number 11,427,565
- Issue date Aug 30, 2022
- Capella Therapeutics, Inc.
- Yun Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...
- Patent number 11,242,352
- Issue date Feb 8, 2022
- Capella Therapeutics, Inc.
- Yun Long
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-substituted quinazoline compounds comprising a substituted hetero...
- Patent number 11,021,470
- Issue date Jun 1, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,975,071
- Issue date Apr 13, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted cinnolines as inhibitors of KRAS G12C
- Patent number 10,927,125
- Issue date Feb 23, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,882,847
- Issue date Jan 5, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,875,842
- Issue date Dec 29, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,858,343
- Issue date Dec 8, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted quinazoline compounds and methods of use thereof
- Patent number 10,829,458
- Issue date Nov 10, 2020
- Araxes Pharma LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,730,867
- Issue date Aug 4, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,723,738
- Issue date Jul 28, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,689,356
- Issue date Jun 23, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...
- Patent number 10,683,304
- Issue date Jun 16, 2020
- Capella Therapeutics, Inc.
- Yun Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,647,703
- Issue date May 12, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...
- Patent number 10,647,707
- Issue date May 12, 2020
- Capella Therapeutics, Inc.
- Yun Long
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazoles for use in the treatment of cancer and inflammatory...
- Patent number 10,590,108
- Issue date Mar 17, 2020
- Capella Therapeutics, Inc.
- Yun Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused-tricyclic inhibitors of KRAS and methods of use thereof
- Patent number 10,428,064
- Issue date Oct 1, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2-substituted quinazoline compounds comprising a substituted hetero...
- Patent number 10,414,757
- Issue date Sep 17, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinolines as inhibitors of KRAS G12C
- Patent number 10,370,386
- Issue date Aug 6, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinazoline compounds and methods of use thereof
- Patent number 10,351,550
- Issue date Jul 16, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- G01 - MEASURING TESTING
Information Patent Grant
Inhibitors of KRAS G12C mutant proteins
- Patent number 10,280,172
- Issue date May 7, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted quinazoline compounds and methods of use thereof
- Patent number 10,246,424
- Issue date Apr 2, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...
- Patent number 10,202,398
- Issue date Feb 12, 2019
- Capella Therapeutics, Inc.
- Yun Long
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted quinazoline compounds and methods of use thereof
- Patent number 10,144,724
- Issue date Dec 4, 2018
- Araxes Pharma LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for inhibition of Ras
- Patent number 10,011,600
- Issue date Jul 3, 2018
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...
- Patent number 10,005,765
- Issue date Jun 26, 2018
- Capella Therapeutics, Inc.
- Yun Long
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for preparation of quinazoline derivatives
- Patent number 9,988,357
- Issue date Jun 5, 2018
- Araxes Pharma LLC
- Neelakandha S. Mani
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C
- Publication number 20240352028
- Publication date Oct 24, 2024
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C
- Publication number 20240043441
- Publication date Feb 8, 2024
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C
- Publication number 20230303586
- Publication date Sep 28, 2023
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZIMIDAZOLES FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY...
- Publication number 20230271938
- Publication date Aug 31, 2023
- Capella Therapeutics, Inc.
- Yun LONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF KRAS G12C
- Publication number 20230212183
- Publication date Jul 6, 2023
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TH...
- Publication number 20220298167
- Publication date Sep 22, 2022
- Capella Therapeutics, Inc.
- Yun LONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C
- Publication number 20220242875
- Publication date Aug 4, 2022
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C
- Publication number 20210188869
- Publication date Jun 24, 2021
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TH...
- Publication number 20210061816
- Publication date Mar 4, 2021
- Capella Therapeutics, Inc.
- Yun LONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZIMIDAZOLE DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS AND METH...
- Publication number 20200291007
- Publication date Sep 17, 2020
- Capella Therapeutics, Inc.
- Yun LONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZIMIDAZOLES FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY...
- Publication number 20200216419
- Publication date Jul 9, 2020
- Capella Therapeutics, Inc.
- Yun LONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-SUBSTITUTED QUINAZOLINE COMPOUNDS COMPRISING A SUBSTITUTED HETERO...
- Publication number 20200181123
- Publication date Jun 11, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C
- Publication number 20200102321
- Publication date Apr 2, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20200062761
- Publication date Feb 27, 2020
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20190284144
- Publication date Sep 19, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TH...
- Publication number 20190169204
- Publication date Jun 6, 2019
- Capella Therapeutics, Inc.
- Yun LONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20190092767
- Publication date Mar 28, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20190055211
- Publication date Feb 21, 2019
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20180319775
- Publication date Nov 8, 2018
- ARAXES PHARMA LLC
- Liansheng LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TH...
- Publication number 20180291012
- Publication date Oct 11, 2018
- Capella Therapeutics, Inc.
- Yun LONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20180282307
- Publication date Oct 4, 2018
- ARAXES PHARMA LLC
- Liansheng LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20180282308
- Publication date Oct 4, 2018
- ARAXES PHARMA LLC
- Liansheng LI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZIMIDAZOLES FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY...
- Publication number 20180273511
- Publication date Sep 27, 2018
- Capella Therapeutics, Inc.
- Yun LONG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20180273515
- Publication date Sep 27, 2018
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20180273523
- Publication date Sep 27, 2018
- ARAXES PHARMA LLC
- Liansheng LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF
- Publication number 20180194748
- Publication date Jul 12, 2018
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF KRAS G12C MUTANT PROTEINS
- Publication number 20180155348
- Publication date Jun 7, 2018
- ARAXES PHARMA LLC
- Liansheng Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C
- Publication number 20180118757
- Publication date May 3, 2018
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED-TRICYCLIC INHIBITORS OF KRAS AND METHODS OF USE THEREOF
- Publication number 20180086753
- Publication date Mar 29, 2018
- ARAXES PHARMA LLC
- Liansheng Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITION OF RAS
- Publication number 20170247376
- Publication date Aug 31, 2017
- Araxes Pharma LLC
- Liansheng LI
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Person

Patents Grantslast 30 patents

Substituted quinazolines as inhibitors of KRAS G12C

Benzimidazole derivatives, and pharmaceutical compositions and meth...

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...

Benzimidazoles for use in the treatment of cancer and inflammatory...

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...

2-substituted quinazoline compounds comprising a substituted hetero...

Inhibitors of KRAS G12C mutant proteins

Substituted cinnolines as inhibitors of KRAS G12C

Inhibitors of KRAS G12C mutant proteins

Inhibitors of KRAS G12C mutant proteins

Inhibitors of KRAS G12C mutant proteins

Substituted quinazoline compounds and methods of use thereof

Inhibitors of KRAS G12C mutant proteins

Inhibitors of KRAS G12C mutant proteins

Inhibitors of KRAS G12C mutant proteins

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...

Inhibitors of KRAS G12C mutant proteins

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...

Benzimidazoles for use in the treatment of cancer and inflammatory...

Fused-tricyclic inhibitors of KRAS and methods of use thereof

2-substituted quinazoline compounds comprising a substituted hetero...

Substituted quinolines as inhibitors of KRAS G12C

Substituted quinazoline compounds and methods of use thereof

Inhibitors of KRAS G12C mutant proteins

Substituted quinazoline compounds and methods of use thereof

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...

Substituted quinazoline compounds and methods of use thereof

Methods and compositions for inhibition of Ras

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for th...

Methods for preparation of quinazoline derivatives

Patents Applicationslast 30 patents

SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C

INHIBITORS OF KRAS G12C

INHIBITORS OF KRAS G12C

BENZIMIDAZOLES FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY...

INHIBITORS OF KRAS G12C

BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TH...

INHIBITORS OF KRAS G12C

INHIBITORS OF KRAS G12C

BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TH...

BENZIMIDAZOLE DERIVATIVES, AND PHARMACEUTICAL COMPOSITIONS AND METH...

BENZIMIDAZOLES FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY...

2-SUBSTITUTED QUINAZOLINE COMPOUNDS COMPRISING A SUBSTITUTED HETERO...

SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C

INHIBITORS OF KRAS G12C MUTANT PROTEINS

SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF

BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TH...

INHIBITORS OF KRAS G12C MUTANT PROTEINS

INHIBITORS OF KRAS G12C MUTANT PROTEINS

INHIBITORS OF KRAS G12C MUTANT PROTEINS

BENZIMIDAZOLE DERIVATIVES AS ERBB TYROSINE KINASE INHIBITORS FOR TH...

INHIBITORS OF KRAS G12C MUTANT PROTEINS

INHIBITORS OF KRAS G12C MUTANT PROTEINS

BENZIMIDAZOLES FOR USE IN THE TREATMENT OF CANCER AND INFLAMMATORY...

INHIBITORS OF KRAS G12C MUTANT PROTEINS

INHIBITORS OF KRAS G12C MUTANT PROTEINS

SUBSTITUTED QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF

INHIBITORS OF KRAS G12C MUTANT PROTEINS

SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C

FUSED-TRICYCLIC INHIBITORS OF KRAS AND METHODS OF USE THEREOF

METHODS AND COMPOSITIONS FOR INHIBITION OF RAS